Literature DB >> 33402129

Development and validation of nomograms to intraoperatively predict metastatic patterns in regional lymph nodes in patients diagnosed with esophageal cancer.

Fei Zhao1, Rong-Xin Lu1, Jin-Yuan Liu1, Jun Fan1, Hao-Ran Lin1, Xiao-Yu Yang1, Shu-Hui You1, Qian-Ge Wu1, Xue-Yun Qin1, Yi Liu1, Fu-Xi Zhen2, Jin-Hua Luo3, Wei Wang4.   

Abstract

BACKGROUND: An accurate intraoperative prediction of lymph node metastatic risk can help surgeons in choosing precise surgical procedures. We aimed to develop and validate nomograms to intraoperatively predict patterns of regional lymph node (LN) metastasis in patients with esophageal cancer.
METHODS: The prediction model was developed in a training cohort consisting of 487 patients diagnosed with esophageal cancer who underwent esophagectomy with complete LN dissection from January 2016 to December 2016. Univariate and multivariable logistic regression were used to identify independent risk factors that were incorporated into a prediction model and used to construct a nomogram. Contrast-enhanced computed tomography reported LN status and was an important comparative factor of clinical usefulness in a validation cohort. Nomogram performance was assessed in terms of calibration, discrimination, and clinical usefulness. An independent validation cohort comprised 206 consecutive patients from January 2017 to December 2017.
RESULTS: Univariate analysis and multivariable logistic regression revealed three independent predictors of metastatic regional LNs, three independent predictors of continuous regional LNs, and two independent predictors of skipping regional LNs. Independent predictors were used to build three individualized prediction nomograms. The models showed good calibration and discrimination, with area under the curve (AUC) values of 0.737, 0.738, and 0.707. Application of the nomogram in the validation cohort yielded good calibration and discrimination, with AUC values of 0.728, 0.668, and 0.657. Decision curve analysis demonstrated that the three nomograms were clinically useful in the validation cohort.
CONCLUSION: This study presents three nomograms that incorporate clinicopathologic factors, which can be used to facilitate the intraoperative prediction of metastatic regional LN patterns in patients with esophageal cancer.

Entities:  

Keywords:  Esophageal cancer; Metastasis; Multivariable logistic model; Nomogram; Regional lymph node

Mesh:

Year:  2021        PMID: 33402129      PMCID: PMC7786479          DOI: 10.1186/s12885-020-07738-9

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  26 in total

Review 1.  Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.

Authors:  B Kayani; E Zacharakis; K Ahmed; G B Hanna
Journal:  Eur J Surg Oncol       Date:  2011-09       Impact factor: 4.424

2.  Prognostic relevance of skip metastases in esophageal cancer.

Authors:  Klaus L Prenzel; Elfriede Bollschweiler; Wolfgang Schröder; Stefan P Mönig; Uta Drebber; Daniel Vallboehmer; Arnulf H Hölscher
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

3.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.

Authors:  Mahul B Amin; Frederick L Greene; Stephen B Edge; Carolyn C Compton; Jeffrey E Gershenwald; Robert K Brookland; Laura Meyer; Donna M Gress; David R Byrd; David P Winchester
Journal:  CA Cancer J Clin       Date:  2017-01-17       Impact factor: 508.702

Review 4.  Strategies of nodal staging of the TNM system for esophageal cancer.

Authors:  Wen-Ping Wang; Song-Lin He; Yu-Shang Yang; Long-Qi Chen
Journal:  Ann Transl Med       Date:  2018-02

5.  A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.

Authors:  Shaoxu Wu; Junjiong Zheng; Yong Li; Hao Yu; Siya Shi; Weibin Xie; Hao Liu; Yangfan Su; Jian Huang; Tianxin Lin
Journal:  Clin Cancer Res       Date:  2017-09-05       Impact factor: 12.531

6.  N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?

Authors:  K G Foley; W G Lewis; P Fielding; A Karran; D Chan; P Blake; S A Roberts
Journal:  Clin Radiol       Date:  2014-06-07       Impact factor: 2.350

Review 7.  Lymphatic spreading and lymphadenectomy for esophageal carcinoma.

Authors:  Xiang Ji; Jie Cai; Yao Chen; Long-Qi Chen
Journal:  World J Gastrointest Surg       Date:  2016-01-27

8.  Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma.

Authors:  Byung-Hoon Min; Jung Wook Yang; Yang Won Min; Sun-Young Baek; Seonwoo Kim; Hong Kwan Kim; Yong Soo Choi; Young Mog Shim; Yoon-La Choi; Jae Ill Zo
Journal:  J Gastroenterol Hepatol       Date:  2019-12-15       Impact factor: 4.029

9.  A nomogram prediction model for recurrent laryngeal nerve lymph node metastasis in thoracic oesophageal squamous cell carcinoma.

Authors:  Yu Liu; Zhi-Qiang Zou; Juan Xiao; Mei Zhang; Lei Yuan; Xiao-Gang Zhao
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

10.  The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer.

Authors:  Eisuke Booka; Hiroya Takeuchi; Tomohiko Nishi; Satoru Matsuda; Takuji Kaburagi; Kazumasa Fukuda; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirofumi Kawakubo; Tai Omori; Yuko Kitagawa
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more
  2 in total

1.  A nomogram model for predicting prognosis of obstructive colorectal cancer.

Authors:  Jian Lv; Yuan Yuan Liu; Yi Tao Jia; Jing Li He; Guang Yao Dai; Peng Guo; Zhao Long Zhao; Yan Ni Zhang; Zhong Xin Li
Journal:  World J Surg Oncol       Date:  2021-12-02       Impact factor: 2.754

2.  Radiomics Analysis of Lymph Nodes with Esophageal Squamous Cell Carcinoma Based on Deep Learning.

Authors:  Li Chen; Yi Ouyang; Shuang Liu; Jie Lin; Changhuan Chen; Caixia Zheng; Jianbo Lin; Zhijian Hu; Moliang Qiu
Journal:  J Oncol       Date:  2022-09-13       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.